CLASS ACTION UPDATE for CLVT, SLI and AFIB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / March 6, 2022 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

CLVT Shareholders Click Here: https://www.zlk.com/pslra-1/clarivate-plc-loss-submission-form?prid=24340&wire=1
SLI Shareholders Click Here: https://www.zlk.com/pslra-1/standard-lithium-ltd-loss-submission-form?prid=24340&wire=1
AFIB Shareholders Click Here: https://www.zlk.com/pslra-1/acutus-medical-inc-loss-submission-form?prid=24340&wire=1

* ADDITIONAL INFORMATION BELOW *

Clarivate Plc CLVT

CLVT Lawsuit on behalf of: investors who purchased February 26, 2021 - December 27, 2021
Lead Plaintiff Deadline : March 25, 2022
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/clarivate-plc-loss-submission-form?prid=24340&wire=1

According to the filed complaint, during the class period, Clarivate Plc made materially false and/or misleading statements and/or failed to disclose that: (i) Clarivate maintained defective disclosure controls and procedures as a result of a material weakness in its internal control over financial reporting; (ii) the foregoing material weakness was not limited to how the Company accounted for warrants; (iii) as a result, Clarivate failed to properly account for an equity plan included in its acquisition of CPA Global, a global leader in Intellectual Property software and tech-enabled services; (iv) accordingly, the Company was reasonably likely to restate one or more of its previously issued financial statements following its acquisition of CPA Global; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

Standard Lithium Ltd. SLI

SLI Lawsuit on behalf of: investors who purchased May 19, 2020 - November 17, 2021
Lead Plaintiff Deadline : March 28, 2022
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/standard-lithium-ltd-loss-submission-form?prid=24340&wire=1

According to the filed complaint, during the class period, Standard Lithium Ltd. made materially false and/or misleading statements and/or failed to disclose that: (i) the LiSTR Direct Lithium Extraction technology's extraction recovery efficiencies were overstated; (ii) accordingly, the Company's final product lithium recovery percentage at the Demonstration Plant would not be as high as the Company had represented to investors; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Acutus Medical, Inc. AFIB

This lawsuit is on behalf of all purchasers of Acutus common stock between May 13, 2021 and November 11, 2021, inclusive.
Lead Plaintiff Deadline : April 18, 2022
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/acutus-medical-inc-loss-submission-form?prid=24340&wire=1

According to the filed complaint, (a) a material percentage of the Company's AcQMap imaging and mapping systems under evaluation had been randomly installed at sites with little, if any, consideration given to whether the healthcare providers at the selected locations were likely to adopt, or desire, the Company's products; (b) a material percentage of the AcQMap systems under evaluation had been installed in locations where the Company did not possess the infrastructure necessary to appropriately educate, train, and support medical service providers on the system's operations; (c) as a result of (a) and (b) above, defendants were in the process of designing a strategic plan to terminate and relocate approximately 20% of then-existing AcQMap systems evaluation arrangements; (d) the Company's management discussion and analysis was materially false and misleading and failed to disclose that the termination and relocation of approximately 20% of existing AcQMap systems evaluation arrangements was reasonably likely to have a material adverse effect on the Company's 2021 financial results; and (e) the Company's risk factor discussions were materially false and misleading and made reference to potential risks without disclosing that such risks were then-existing or adequately describing the specific nature of the risks then facing the Company.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP